NEK2 and head and neck squamous cell carcinoma: Our results revealed that patients with head and neck squamous cell carcinoma (HNSC), who had both high CAI and high Nek2A levels experienced notably better survival compared to those with high CAI but low Nek2A levels (Fig. 7A).